Skip to Main Content

Author Details

Elizabeth N Kornaga
Tom Baker Cancer Centre
2012
23
11
PMIDPaper TitleJournal TitlePublished Year
37668363Prevalence and Prognostic Significance of PIK3CA Mutation and CNV Status and Phosphorylated AKT Expression in Patients With Cervical Cancer Treated With Primary Surgery.Int J Gynecol Pathol2024
35049708Survival in Women with De Novo Metastatic Breast Cancer: A Comparison of Real-World Evidence from a Publicly-Funded Canadian Province and the United States by Insurance Status.Curr Oncol2022
35565297Combining TMEM Doorway Score and Mena<sup>Calc</sup> Score Improves the Prediction of Distant Recurrence Risk in HR+/HER2- Breast Cancer Patients.Cancers (Basel)2022
36276142The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy.Front Oncol2022
34238931Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.NPJ Breast Cancer2021
32653099PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer.Gynecol Oncol2020
32881987Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.PLoS One2020
30143750An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.Mod Pathol2019
35100692Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers.JCO Precis Oncol2019
28059093Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer.Mod Pathol2017
28131528Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.Gynecol Oncol2017
28126304Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.Int J Radiat Oncol Biol Phys2017
28493978Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.PLoS One2017
29594208Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study.Clin Transl Radiat Oncol2017
29098033Impact of tumoral carbonic anhydrase IX and Ki-67 expression on survival in oral squamous cell carcinoma patients.Oncol Lett2017
27489350Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.Oncotarget2016
27741524Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer.Oncotarget2016
27125355A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort.Mod Pathol2016
27562489Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.Mod Pathol2016
25976920Fractal analysis of nuclear histology integrates tumor and stromal features into a single prognostic factor of the oral cancer microenvironment.BMC Cancer2015
25935535Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer.Breast Cancer Res2015
24912621Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients.Oncotarget2014
22852863Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.BMC Cancer2012
  • 1 - 23 of 23

Recommended Authors

Martin Sj??str??m
University of California-San Francisco
Career Start Year 2013
Number of shared co-authors 1
Ghassan Allo
Henry Ford Hospital
Career Start Year 2011
Number of shared co-authors 3
Juan Moreno
University of Toronto
Career Start Year 2011
Number of shared co-authors 1
Francisco Beca
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 4
Elton Rexhepaj
UCD Conway Institute, University College Dublin
Career Start Year 2007
Number of shared co-authors 0
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 2
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 3
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 1
Karin Jirstr??m
Lund University
Career Start Year 2003
Number of shared co-authors 3
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 2
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 1
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 4
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 4
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 9
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Career Start Year 1995
Number of shared co-authors 6
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 4
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 2
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 3
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 8
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 1
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 1
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 10
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 6
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 5
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Susan P Lees-Miller
University of Calgary, 0 Hospital Drive NW
Co-authored papers 9
John M S Bartlett
University of Edinburgh
Co-authored papers 4
Pinaki Bose
Cumming School of Medicine, University of Calgary
Co-authored papers 4
Jane Bayani
Ontario Institute for Cancer Research
Co-authored papers 4
Joseph C Dort
Cumming School of Medicine, University of Calgary
Co-authored papers 4
Tammy Piper
University of Edinburgh
Co-authored papers 3
Paul C Boutros
University of California los angeles
Co-authored papers 3
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 3
Robert C Stein
12 University College London Hospitals National Health Service Foundation Trust
Co-authored papers 2
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Co-authored papers 2
Cheryl Crozier
Ontario Institute for Cancer Research
Co-authored papers 2
Martin K??bel
University of Calgary
Co-authored papers 2
Janet A Dunn
Warwick Clinical Trials Unit, University of Warwick
Co-authored papers 2
Christos Markopoulos
National and Kapodistrian University of Athens
Co-authored papers 1
Lauren Bathurst
Ontario Institute for Cancer Research
Co-authored papers 1
Melanie Spears
Ontario Institute for Cancer Research
Co-authored papers 1
Quang M Trinh
Ontario Institute for Cancer Research
Co-authored papers 1
Thomas E Rohan
Albert Einstein College of Medicine
Co-authored papers 1
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 1
Arvydas Laurinavicius
Vilnius University
Co-authored papers 1
David L Rimm
Yale University School of Medicine
Co-authored papers 1
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 1
Gun Ho Jang
Ontario Institute for Cancer Research
Co-authored papers 1
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Co-authored papers 1
Shujuan Fang
Charbonneau Cancer Institute, University of Calgary
Co-authored papers 1
John D McPherson
Ontario Institute for Cancer Research
Co-authored papers 1
Lincoln Stein
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 1
Caroline Seynaeve
Erasmus Medical Center
Co-authored papers 1
Keying Xu
Ontario Institute for Cancer Research
Co-authored papers 1
Julie Livingstone
University of California los angeles
Co-authored papers 1
Release 1.2